1. Home
  2. BZAI vs LAB Comparison

BZAI vs LAB Comparison

Compare BZAI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blaize Holdings Inc.

BZAI

Blaize Holdings Inc.

N/A

Current Price

$0.16

Market Cap

268.9M

Sector

N/A

ML Signal

N/A

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

N/A

Current Price

$0.72

Market Cap

270.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BZAI
LAB
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
268.9M
270.6M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
BZAI
LAB
Price
$0.16
$0.72
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $1.75
N/A
AVG Volume (30 Days)
★ 1.7M
758.9K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
43.43
★ 61.54
EPS
N/A
★ 0.29
Revenue
N/A
★ $101,937,000.00
Revenue This Year
$9.24
N/A
Revenue Next Year
$168.89
N/A
P/E Ratio
★ N/A
$2.26
Revenue Growth
★ N/A
N/A
52 Week Low
$0.17
$0.59
52 Week High
$2.82
$1.72

Technical Indicators

Market Signals
Indicator
BZAI
LAB
Relative Strength Index (RSI) 29.15 62.71
Support Level N/A $0.71
Resistance Level $0.23 $0.79
Average True Range (ATR) 0.02 0.04
MACD 0.01 0.01
Stochastic Oscillator 8.76 90.33

Price Performance

Historical Comparison
BZAI
LAB

About BZAI Blaize Holdings Inc.

Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: